ALDH2 polymorphism for the risk of cervical carcinogenesis

Hum Cell. 2016 Apr;29(2):91-5. doi: 10.1007/s13577-016-0133-y. Epub 2016 Feb 3.

Abstract

To investigate the clinical significance of ALDH2 genetic polymorphisms in cervical carcinogenesis. ALDH2 polymorphisms together with human papillomavirus (HPV) types were examined in a total of 195 cervical smear in exfoliated cervical cell samples using Real-Time polymerase chain reaction (PCR) System. The frequency for the AG+AA genotype was seven in the normal group (70.0 %), 16 in the LSIL group (57.1 %), and 27 in the HSIL group (90.0 %). A significant difference was found between the LSIL and HSIL groups (P = 0.0064). Patients with HSIL lesions frequently had high-risk HPV infections and concurrently belonged to the AG+AA group. ALDH2 genotype in cervical cell samples may be associated with more severe precancerous lesions of the cervix in a Japanese population.

Keywords: ALDH2; Cervical carcinogenesis; Polymorphism; SIL.

MeSH terms

  • Aldehyde Dehydrogenase, Mitochondrial / genetics*
  • Female
  • Genetic Association Studies*
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Papillomaviridae / classification
  • Polymorphism, Genetic / genetics*
  • Risk
  • Risk Factors
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / virology

Substances

  • ALDH2 protein, human
  • Aldehyde Dehydrogenase, Mitochondrial